XADAGO® (safinamide) [Full Prescribing Information]. Louisville, KY: US WorldMeds, LLC; May 2017.
Schapira AHV, Fox SH, Hauser RA, et al. Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: a randomized clinical trial. JAMA Neurol. 2017;74(2):216-224.
Borgohain R, Szasz J, Stanzione P, et al. Randomized trial of safinamide add-on to levodopa in Parkinson’s disease with motor fluctuations. Mov Disord. 2014;29(2):229-237.
The information contained in this section of the site is intended for U.S. healthcare providers only.
Click OK if you are a healthcare provider
Before you go!
Learn about gaining more on time without troublesome dyskinesia.
Sign up now to get important information about XADAGO as part of your Parkinson's disease treatment regimen.
*Required information
Where will you XADAGO Next?
Sign up to learn how XADAGO can help increase your daily on time without troublesome dyskinesia and reduce your off time.
